About 10% of colon cancers are inherited, mainly through Lynch syndrome and familial adenomatous polyposis (FAP). Knowing your family history for at least three generations helps identify colon cancer ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

Agilus Diagnostics introduces the Idylla system in Mumbai, enabling rapid genetic mutation testing for precision oncology ...

Previous studies were typically limited to predicting single genetic alterations and did not account for co-occurring mutations or shared morphological patterns. The model detects genetic alterations ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found. Daily aspirin reduced by 55% the risk of cancer recurrence in ...

A new study has answered a question that has puzzled cancer researchers for decades: Does a genetic defect found in nearly all human colorectal cancers simply accompany the disease, or does it trigger ...

An international, interdisciplinary research team led by Prof. Jakob N. Kather from the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology analyzed seven ...

Colorectal cancer is one of the most common cancers in the United States. The good news is that it’s also one of the most ...

JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...

The discovery of a drug called daraxonrasib, which a Florida doctor was part of, could have implications for extending ...